Skip to content

Research on the Establishment and Application of a Nutritional Management Model for Acutely Admitted Elderly Patients with Frailty Complicated by High-Level Inflammation

Research on the Establishment and Application of a Nutritional Management Model for Acutely Admitted Elderly Patients with Frailty Complicated by High-Level Inflammation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100740
Enrollment
Unknown
Registered
2025-04-15
Start date
2025-04-16
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic non-communicable diseases

Interventions

Nutrition Ward Group:Innovative personalized nutrition management and disease treatment plan
Control group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Elderly inpatients aged over 65 years. 2. Elderly inpatients who are willing to participate in and cooperate with the study. 3. Patients who scored >=3 on the FRAIL scale, based on their status two weeks prior to admission. 4. Patients with C-reactive protein (CRP) levels exceeding 100 mg/L, as determined by testing performed either within 24 hours after admission or within 48 hours prior to admission at a medical facility.

Exclusion criteria

Exclusion criteria: 1. Patients (or their family members) who are unwilling to participate in the study or follow-up. 2. Length of hospital stay less than 7 days. 3. Patients with severe comorbidities where death is inevitable and expected within three months (e.g., end-stage organ failure, terminal malignancies with widespread distant metastases). 4. Patients with severe cognitive impairment or progressive neurological diseases that are irreversible or prevent a return to normal life. 5. Patients who have already been enrolled in the study and are readmitted during the study period.

Design outcomes

Primary

MeasureTime frame
MNA-SF score;Combined In-hospital adverse clinical events;

Secondary

MeasureTime frame
Weight;Combined adverse outcome within 180 days;In-hospital adverse clinical events;Length of hospital stay and hospital costs;

Countries

China

Contacts

Public ContactLiu Gongxiang

West China Hospital of Sichuan University

lgx12345672013@163.com+86 189 8071 7369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026